about
Mitochondria: the gateway for tamoxifen-induced liver injury.Interplay between estrogen and retinoid signaling in breast cancer--current and future perspectives.Rethinking tamoxifen in the management of melanoma: New answers for an old question.A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancerPhosphate: from stardust to eukaryotic cell cycle control.Polyphosphate is a key factor for cell survival after DNA damage in eukaryotic cells.Polyphosphate: popping up from oblivion.Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box?Live fast, die soon: cell cycle progression and lifespan in yeast cellsThe combination of glutamate receptor antagonist MK-801 with tamoxifen and its active metabolites potentiates their antiproliferative activity in mouse melanoma K1735-M2 cells.The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen.The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.Effects of all-trans-retinoic acid on the permeability transition and bioenergetic functions of rat liver mitochondria in combination with endoxifen.The antiestrogen endoxifen protects rat liver mitochondria from permeability transition pore opening and oxidative stress at concentrations that do not affect the phosphorylation efficiency.The atypical cyclin CNTD2 promotes colon cancer cell proliferation and migrationPhosphoregulation of the oncogenic protein regulator of cytokinesis 1 (PRC1) by the atypical CDK16/CCNY complexAtypical cyclins: the extended family portraitComprehensive and quantitative analysis of G1 cyclins. A tool for studying the cell cycle
P50
Q38216454-407C31FF-AF1D-4128-A161-E4D530F57C23Q38231813-24DF694E-9E2B-4C7C-BDC2-984B59A3B350Q38545591-9406507A-0384-4168-8F71-5C6DAAF78F36Q38599094-2C51C5C7-1BD3-4B9F-A2CD-3409A197F271Q38685112-2325415D-73B8-4D68-BD13-5A1CD0D7EF86Q38694578-27E9EF8E-DB7D-4A8F-A8D9-C44DD668C2D7Q38843449-6D9C62E7-E61C-4855-9DEA-06AC4540849CQ38944411-83AD52CA-2953-437D-8E31-08E78300E68DQ39208079-872C7EEB-6285-4617-8D21-2DCF756108A4Q44060851-A3F2B5D6-2095-48CF-86EE-2FFAA049F064Q44397464-158C1B79-F04B-4B6D-95DD-8A38C5897DBEQ47744951-45D57AB7-50FC-4BAF-9FC6-0CC61E5DC8DEQ50479022-0DFC42C5-DA51-41F6-B941-CABBB445047EQ52632899-0F0CBF60-C24B-4567-B326-CC968E74D432Q58797903-F6197A6A-EB86-4D5E-80F9-055BEC9CDDC1Q64107889-E1FA8293-A71B-4380-A7C6-01270326551BQ92669414-AB2191EC-3A02-4DEC-8617-D463B969BE1CQ93013715-D137AE5E-DA8B-4BD4-8EAC-19A37734F926
P50
description
investigador
@es
researcher
@en
name
Mariana P C Ribeiro
@en
type
label
Mariana P C Ribeiro
@en
prefLabel
Mariana P C Ribeiro
@en
P31
P496
0000-0001-5258-7921